Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indian Immunologicals is an Indian biopharmaceutical and vaccine manufacturer focused on both animal health and human health, with leading positions in veterinary biologicals and human vaccines in India. Established by the National Dairy Development Board in 1982 and corporatized in 1999, the company manufactures more than 150 products and exports animal and human vaccines to over 50 countries. Its commercial portfolio includes pediatric vaccines, purified vero cell rabies vaccine marketed as Abhayrab, veterinary vaccines, hormones, formulations, and nutraceutical products. The company also maintains an active R&D pipeline spanning human vaccines, veterinary vaccines, fish health products, and anti-rabies monoclonal antibodies. Indian Immunologicals operates large-scale manufacturing facilities in Hyderabad and Ooty and positions itself around a One Health strategy linking animal and human health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indian Immunologicals.